AC Immune (ACIU) Interest Expenses (2015 - 2026)
AC Immune (ACIU) reported Interest Expenses of -$83005.3 for Q1 2026, down 38.2% year-over-year from -$134313.8 in Q1 2025, and down 257.96% on a QoQ basis from $52549.1 in Q4 2025.
AC Immune (ACIU) has 12 years of Interest Expenses data on file, last reported at -$83005.3 in Q1 2026.
- Quarterly Interest Expenses fell 38.2% year-over-year to -$83005.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148355.7 (down 51.26% YoY) and the FY2025 annual result came in at $227958.3, up 52.44% from the prior year.
- Interest Expenses fell to -$83005.3 in Q1 2026 per ACIU's latest filing, from $52549.1 in the prior quarter.
- Across five years, Interest Expenses topped out at $104872.8 in Q1 2023 and bottomed at -$730767.4 in Q4 2022.
- The 5-year median for Interest Expenses is -$41244.6 (2024), against an average of -$77774.1.
- The widest annual swing landed in 2022, when Interest Expenses sank 7438.14%; it then surged 162.89% in 2023.
- Tracing ACIU's Interest Expenses over 5 years: stood at -$730767.4 in 2022, then jumped by 103.86% to $28183.9 in 2023, then surged by 33.66% to $37670.2 in 2024, then surged by 39.5% to $52549.1 in 2025, then sank by 257.96% to -$83005.3 in 2026.
- Per Business Quant, the three latest ACIU Interest Expenses figures stand at -$83005.3 (Q1 2026), $52549.1 (Q4 2025), and -$57505.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | -83,005.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83,005.30 |
| Mar 31, 2026 | -83,005.30 |
| Dec 31, 2025 | 52,549.13 |
| Dec 31, 2025 | 52,549.13 |
| Sep 30, 2025 | -57,505.04 |
| Sep 30, 2025 | -57,505.04 |
| Jun 30, 2025 | -60,394.51 |
| Jun 30, 2025 | -60,394.51 |
| Mar 31, 2025 | -60,061.53 |
| Mar 31, 2025 | -60,061.53 |
| Dec 31, 2024 | 37,670.22 |
| Dec 31, 2024 | 37,670.22 |
| Sep 30, 2024 | -38,088.84 |
| Sep 30, 2024 | -38,088.84 |
| Jun 30, 2024 | -37,596.98 |
| Jun 30, 2024 | -37,596.98 |
| Mar 31, 2024 | 40,098.88 |
| Mar 31, 2024 | 40,098.88 |
| Dec 31, 2023 | -29,311.22 |
| Dec 31, 2023 | -29,311.22 |
| Sep 30, 2023 | -29,435.97 |
| Sep 30, 2023 | -29,435.97 |
| Jun 30, 2023 | -30,028.74 |
| Jun 30, 2023 | -30,028.74 |
| Mar 31, 2023 | -104,872.77 |
| Mar 31, 2023 | -104,872.77 |
| Dec 31, 2022 | 1,038.02 |
| Dec 31, 2022 | 1,038.02 |
| Sep 30, 2022 | -79,730.16 |
| Sep 30, 2022 | -79,730.16 |
| Jun 30, 2022 | -130,824.92 |
| Jun 30, 2022 | -130,824.92 |
| Mar 31, 2022 | -166,752.49 |
| Mar 31, 2022 | -166,752.49 |
| Dec 31, 2021 | -624,673.21 |
| Dec 31, 2021 | -624,673.21 |
| Sep 30, 2021 | -197,132.37 |
| Sep 30, 2021 | -197,132.37 |
| Jun 30, 2021 | -221,522.72 |
| Jun 30, 2021 | -221,522.72 |
| Mar 31, 2021 | -2,212.12 |
| Mar 31, 2021 | -2,212.12 |
| Dec 31, 2020 | -27,653.89 |
| Dec 31, 2020 | -27,653.89 |
| Sep 30, 2020 | -49,972.81 |
| Sep 30, 2020 | -49,972.81 |
| Jun 30, 2020 | -58,117.47 |
| Jun 30, 2020 | -58,117.47 |
| Mar 31, 2020 | -4,135.39 |
| Mar 31, 2020 | -4,135.39 |
| Dec 31, 2019 | -26,269.97 |
| Dec 31, 2019 | -26,269.97 |
| Sep 30, 2019 | -87,285.82 |
| Sep 30, 2019 | -87,285.82 |
| Jun 30, 2019 | -502,643.18 |
| Jun 30, 2019 | -502,643.18 |
| Mar 31, 2019 | -3,012.19 |
| Mar 31, 2019 | -3,012.19 |
| Dec 31, 2018 | -372,793.71 |
| Dec 31, 2018 | -372,793.71 |
| Sep 30, 2018 | -31,508.06 |
| Sep 30, 2018 | -31,508.06 |
| Jun 30, 2018 | -22,351.01 |
| Jun 30, 2018 | -22,351.01 |
| Mar 31, 2018 | 13,707.28 |
| Mar 31, 2018 | 13,707.28 |
| Dec 31, 2017 | 7.96 Mn |
| Dec 31, 2017 | 7.96 Mn |
| Sep 30, 2017 | -8.31 Mn |
| Sep 30, 2017 | -8.31 Mn |
| Jun 30, 2017 | 1.65 Mn |
| Jun 30, 2017 | 1.65 Mn |
| Mar 31, 2017 | -1.63 Mn |
| Mar 31, 2017 | -1.63 Mn |
| Dec 31, 2016 | -135,003.30 |
| Dec 31, 2016 | -135,003.30 |
| Sep 30, 2016 | -1.09 Mn |
| Sep 30, 2016 | -1.09 Mn |
| Jun 30, 2016 | -116,462.11 |
| Jun 30, 2016 | -116,462.11 |
| Mar 31, 2016 | -3,020.75 |
| Mar 31, 2016 | -3,020.75 |
| Dec 31, 2015 | -27,284.36 |
| Dec 31, 2015 | -27,284.36 |
| Sep 30, 2015 | -55,008.05 |
| Sep 30, 2015 | -55,008.05 |